A/H5N1 Vaccine in Healthy Children Aged 2-9 Years

NCT00133536 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

157

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza A/H5N1 Vaccine
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)